Background Post-chemotherapy cognitive impairment commonly known as “chemobrain” or “chemofog” is a well-established clinical disorder affecting various cognitive domains including attention, visuospatial working memory, executive function, etc. Although several studies have confirmed the chemobrain in recent years, scant experiments have evaluated the potential neurotoxicity of different chemotherapy regimens and agents. In this study, we aimed to evaluate the extent of attention deficits, one of the commonly affected cognitive domains, among breast cancer patients treated with different chemotherapy regimens through neuroimaging techniques.

中文翻译：

---

接受不同化疗方案的乳腺癌幸存者的神经相关性和功能认知图；基于 QEEG/HEG 的调查

背景化疗后认知障碍通常被称为“chemobrain”或“chemofog”，是一种公认​​的临床障碍，影响注意力、视觉空间工作记忆、执行功能等多个认知领域。 尽管近年来有多项研究证实了chemobrain，很少有实验评估不同化疗方案和药物的潜在神经毒性。在这项研究中，我们旨在通过神经影像技术评估接受不同化疗方案的乳腺癌患者的注意力缺陷程度，这是一种常见的认知领域。